Personal information

Activities

Employment (1)

University Hospital Muenster: Muenster, DE

Chair (Institute of Pathology)
Employment
Source: Self-asserted source
Eva Wardelmann

Education and qualifications (1)

University Hospital Muenster: Muenster, DE

2013-10-01 to present | Prof. Dr. med. (Institute of Pathology)
Education
Source: Self-asserted source
Eva Wardelmann

Works (50 of 96)

Items per page:
Page 1 of 2

Data from Interdependence of SS18-SSX-driven YAP1 and β-catenin activation in synovial sarcoma

2024-09-16 | Preprint
Contributors: Ilka Isfort; Ruth Berthold; Lorena Heinst; Eva Wardelmann; Olle Larsson; Marcel Trautmann; Wolfgang Hartmann
Source: check_circle
Crossref

Data from Interdependence of SS18-SSX-driven YAP1 and β-catenin activation in synovial sarcoma

2024-09-16 | Preprint
Contributors: Ilka Isfort; Ruth Berthold; Lorena Heinst; Eva Wardelmann; Olle Larsson; Marcel Trautmann; Wolfgang Hartmann
Source: check_circle
Crossref

Data from KIT And PDGFRA Mutations And Survival of Gastrointestinal Stromal Tumor Patients Treated With Adjuvant Imatinib in a Randomized Trial

2024-09-16 | Preprint
Contributors: Heikki Joensuu; Eva Wardelmann; Mikael Eriksson; Annette Reichardt; Kirsten Sundby Hall; Jochen Schütte; Silke Cameron; Peter Hohenberger; Harri Sihto; Philipp J. Jost et al.
Source: check_circle
Crossref

Data from KIT And PDGFRA Mutations And Survival of Gastrointestinal Stromal Tumor Patients Treated With Adjuvant Imatinib in a Randomized Trial

2024-09-16 | Preprint
Contributors: Heikki Joensuu; Eva Wardelmann; Mikael Eriksson; Annette Reichardt; Kirsten Sundby Hall; Jochen Schütte; Silke Cameron; Peter Hohenberger; Harri Sihto; Philipp J. Jost et al.
Source: check_circle
Crossref

Figure S1 from Interdependence of SS18-SSX-driven YAP1 and β-catenin activation in synovial sarcoma

2024-09-16 | Preprint
Contributors: Ilka Isfort; Ruth Berthold; Lorena Heinst; Eva Wardelmann; Olle Larsson; Marcel Trautmann; Wolfgang Hartmann
Source: check_circle
Crossref

Figure S1 from Interdependence of SS18-SSX-driven YAP1 and β-catenin activation in synovial sarcoma

2024-09-16 | Preprint
Contributors: Ilka Isfort; Ruth Berthold; Lorena Heinst; Eva Wardelmann; Olle Larsson; Marcel Trautmann; Wolfgang Hartmann
Source: check_circle
Crossref

Figure S2 from Interdependence of SS18-SSX-driven YAP1 and β-catenin activation in synovial sarcoma

2024-09-16 | Preprint
Contributors: Ilka Isfort; Ruth Berthold; Lorena Heinst; Eva Wardelmann; Olle Larsson; Marcel Trautmann; Wolfgang Hartmann
Source: check_circle
Crossref

Figure S2 from Interdependence of SS18-SSX-driven YAP1 and β-catenin activation in synovial sarcoma

2024-09-16 | Preprint
Contributors: Ilka Isfort; Ruth Berthold; Lorena Heinst; Eva Wardelmann; Olle Larsson; Marcel Trautmann; Wolfgang Hartmann
Source: check_circle
Crossref

Figure S3 from Interdependence of SS18-SSX-driven YAP1 and β-catenin activation in synovial sarcoma

2024-09-16 | Preprint
Contributors: Ilka Isfort; Ruth Berthold; Lorena Heinst; Eva Wardelmann; Olle Larsson; Marcel Trautmann; Wolfgang Hartmann
Source: check_circle
Crossref

Figure S3 from Interdependence of SS18-SSX-driven YAP1 and β-catenin activation in synovial sarcoma

2024-09-16 | Preprint
Contributors: Ilka Isfort; Ruth Berthold; Lorena Heinst; Eva Wardelmann; Olle Larsson; Marcel Trautmann; Wolfgang Hartmann
Source: check_circle
Crossref

Figure S4 from Interdependence of SS18-SSX-driven YAP1 and β-catenin activation in synovial sarcoma

2024-09-16 | Preprint
Contributors: Ilka Isfort; Ruth Berthold; Lorena Heinst; Eva Wardelmann; Olle Larsson; Marcel Trautmann; Wolfgang Hartmann
Source: check_circle
Crossref

Figure S4 from Interdependence of SS18-SSX-driven YAP1 and β-catenin activation in synovial sarcoma

2024-09-16 | Preprint
Contributors: Ilka Isfort; Ruth Berthold; Lorena Heinst; Eva Wardelmann; Olle Larsson; Marcel Trautmann; Wolfgang Hartmann
Source: check_circle
Crossref

Figure S5 from Interdependence of SS18-SSX-driven YAP1 and β-catenin activation in synovial sarcoma

2024-09-16 | Preprint
Contributors: Ilka Isfort; Ruth Berthold; Lorena Heinst; Eva Wardelmann; Olle Larsson; Marcel Trautmann; Wolfgang Hartmann
Source: check_circle
Crossref

Figure S5 from Interdependence of SS18-SSX-driven YAP1 and β-catenin activation in synovial sarcoma

2024-09-16 | Preprint
Contributors: Ilka Isfort; Ruth Berthold; Lorena Heinst; Eva Wardelmann; Olle Larsson; Marcel Trautmann; Wolfgang Hartmann
Source: check_circle
Crossref

Figure S6 from Interdependence of SS18-SSX-driven YAP1 and β-catenin activation in synovial sarcoma

2024-09-16 | Preprint
Contributors: Ilka Isfort; Ruth Berthold; Lorena Heinst; Eva Wardelmann; Olle Larsson; Marcel Trautmann; Wolfgang Hartmann
Source: check_circle
Crossref

Figure S6 from Interdependence of SS18-SSX-driven YAP1 and β-catenin activation in synovial sarcoma

2024-09-16 | Preprint
Contributors: Ilka Isfort; Ruth Berthold; Lorena Heinst; Eva Wardelmann; Olle Larsson; Marcel Trautmann; Wolfgang Hartmann
Source: check_circle
Crossref

Study Protocol from KIT And PDGFRA Mutations And Survival of Gastrointestinal Stromal Tumor Patients Treated With Adjuvant Imatinib in a Randomized Trial

2024-09-16 | Preprint
Contributors: Heikki Joensuu; Eva Wardelmann; Mikael Eriksson; Annette Reichardt; Kirsten Sundby Hall; Jochen Schütte; Silke Cameron; Peter Hohenberger; Harri Sihto; Philipp J. Jost et al.
Source: check_circle
Crossref

Study Protocol from KIT And PDGFRA Mutations And Survival of Gastrointestinal Stromal Tumor Patients Treated With Adjuvant Imatinib in a Randomized Trial

2024-09-16 | Preprint
Contributors: Heikki Joensuu; Eva Wardelmann; Mikael Eriksson; Annette Reichardt; Kirsten Sundby Hall; Jochen Schütte; Silke Cameron; Peter Hohenberger; Harri Sihto; Philipp J. Jost et al.
Source: check_circle
Crossref

Supplementary Figure S1 from KIT And PDGFRA Mutations And Survival of Gastrointestinal Stromal Tumor Patients Treated With Adjuvant Imatinib in a Randomized Trial

2024-09-16 | Preprint
Contributors: Heikki Joensuu; Eva Wardelmann; Mikael Eriksson; Annette Reichardt; Kirsten Sundby Hall; Jochen Schütte; Silke Cameron; Peter Hohenberger; Harri Sihto; Philipp J. Jost et al.
Source: check_circle
Crossref

Supplementary Figure S1 from KIT And PDGFRA Mutations And Survival of Gastrointestinal Stromal Tumor Patients Treated With Adjuvant Imatinib in a Randomized Trial

2024-09-16 | Preprint
Contributors: Heikki Joensuu; Eva Wardelmann; Mikael Eriksson; Annette Reichardt; Kirsten Sundby Hall; Jochen Schütte; Silke Cameron; Peter Hohenberger; Harri Sihto; Philipp J. Jost et al.
Source: check_circle
Crossref

Supplementary Figure S2 from KIT And PDGFRA Mutations And Survival of Gastrointestinal Stromal Tumor Patients Treated With Adjuvant Imatinib in a Randomized Trial

2024-09-16 | Preprint
Contributors: Heikki Joensuu; Eva Wardelmann; Mikael Eriksson; Annette Reichardt; Kirsten Sundby Hall; Jochen Schütte; Silke Cameron; Peter Hohenberger; Harri Sihto; Philipp J. Jost et al.
Source: check_circle
Crossref

Supplementary Figure S2 from KIT And PDGFRA Mutations And Survival of Gastrointestinal Stromal Tumor Patients Treated With Adjuvant Imatinib in a Randomized Trial

2024-09-16 | Preprint
Contributors: Heikki Joensuu; Eva Wardelmann; Mikael Eriksson; Annette Reichardt; Kirsten Sundby Hall; Jochen Schütte; Silke Cameron; Peter Hohenberger; Harri Sihto; Philipp J. Jost et al.
Source: check_circle
Crossref

Supplementary Figure S3 from KIT And PDGFRA Mutations And Survival of Gastrointestinal Stromal Tumor Patients Treated With Adjuvant Imatinib in a Randomized Trial

2024-09-16 | Preprint
Contributors: Heikki Joensuu; Eva Wardelmann; Mikael Eriksson; Annette Reichardt; Kirsten Sundby Hall; Jochen Schütte; Silke Cameron; Peter Hohenberger; Harri Sihto; Philipp J. Jost et al.
Source: check_circle
Crossref

Supplementary Figure S3 from KIT And PDGFRA Mutations And Survival of Gastrointestinal Stromal Tumor Patients Treated With Adjuvant Imatinib in a Randomized Trial

2024-09-16 | Preprint
Contributors: Heikki Joensuu; Eva Wardelmann; Mikael Eriksson; Annette Reichardt; Kirsten Sundby Hall; Jochen Schütte; Silke Cameron; Peter Hohenberger; Harri Sihto; Philipp J. Jost et al.
Source: check_circle
Crossref

Supplementary Table S1 from KIT And PDGFRA Mutations And Survival of Gastrointestinal Stromal Tumor Patients Treated With Adjuvant Imatinib in a Randomized Trial

2024-09-16 | Preprint
Contributors: Heikki Joensuu; Eva Wardelmann; Mikael Eriksson; Annette Reichardt; Kirsten Sundby Hall; Jochen Schütte; Silke Cameron; Peter Hohenberger; Harri Sihto; Philipp J. Jost et al.
Source: check_circle
Crossref

Supplementary Table S1 from KIT And PDGFRA Mutations And Survival of Gastrointestinal Stromal Tumor Patients Treated With Adjuvant Imatinib in a Randomized Trial

2024-09-16 | Preprint
Contributors: Heikki Joensuu; Eva Wardelmann; Mikael Eriksson; Annette Reichardt; Kirsten Sundby Hall; Jochen Schütte; Silke Cameron; Peter Hohenberger; Harri Sihto; Philipp J. Jost et al.
Source: check_circle
Crossref

Gastrointestinale Stromatumoren

Die Pathologie
2024-05 | Journal article
Contributors: Eva Wardelmann; Anna Kuntze; Artem Voloshin; Sandra Elges; Marcel Trautmann; Wolfgang Hartmann
Source: check_circle
Crossref

A Systematic Review and Illustrative Case Presentation of Low-Grade Myofibroblastic Sarcoma (LGMS) of the Extremities

Journal of Clinical Medicine
2023-11-10 | Journal article
Contributors: Astrid Schenker; Ewgenija Gutjahr; Burkhard Lehner; Gunhild Mechtersheimer; Eva Wardelmann; Rosa Klotz; Eva Kalkum; Marcus Schiltenwolf; Leila Harhaus; Tobias Renkawitz et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Data from <i>KIT</i> and <i>PDGFRA</i> Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial

2023-09-01 | Preprint
Contributors: Heikki Joensuu; Eva Wardelmann; Mikael Eriksson; Annette Reichardt; Kirsten Sundby Hall; Jochen Schütte; Silke Cameron; Peter Hohenberger; Harri Sihto; Philipp J. Jost et al.
Source: check_circle
Crossref

KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial

Clinical Cancer Research
2023-09-01 | Journal article
Contributors: Heikki Joensuu; Eva Wardelmann; Mikael Eriksson; Annette Reichardt; Kirsten Sundby Hall; Jochen Schütte; Silke Cameron; Peter Hohenberger; Harri Sihto; Philipp J. Jost et al.
Source: check_circle
Crossref

Study Protocol from <i>KIT</i> and <i>PDGFRA</i> Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial

2023-09-01 | Preprint
Contributors: Heikki Joensuu; Eva Wardelmann; Mikael Eriksson; Annette Reichardt; Kirsten Sundby Hall; Jochen Schütte; Silke Cameron; Peter Hohenberger; Harri Sihto; Philipp J. Jost et al.
Source: check_circle
Crossref

Study Protocol from <i>KIT</i> and <i>PDGFRA</i> Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial

2023-09-01 | Preprint
Contributors: Heikki Joensuu; Eva Wardelmann; Mikael Eriksson; Annette Reichardt; Kirsten Sundby Hall; Jochen Schütte; Silke Cameron; Peter Hohenberger; Harri Sihto; Philipp J. Jost et al.
Source: check_circle
Crossref

Supplementary Figure S1 from <i>KIT</i> and <i>PDGFRA</i> Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial

2023-09-01 | Preprint
Contributors: Heikki Joensuu; Eva Wardelmann; Mikael Eriksson; Annette Reichardt; Kirsten Sundby Hall; Jochen Schütte; Silke Cameron; Peter Hohenberger; Harri Sihto; Philipp J. Jost et al.
Source: check_circle
Crossref

Supplementary Figure S1 from <i>KIT</i> and <i>PDGFRA</i> Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial

2023-09-01 | Preprint
Contributors: Heikki Joensuu; Eva Wardelmann; Mikael Eriksson; Annette Reichardt; Kirsten Sundby Hall; Jochen Schütte; Silke Cameron; Peter Hohenberger; Harri Sihto; Philipp J. Jost et al.
Source: check_circle
Crossref

Supplementary Figure S2 from <i>KIT</i> and <i>PDGFRA</i> Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial

2023-09-01 | Preprint
Contributors: Heikki Joensuu; Eva Wardelmann; Mikael Eriksson; Annette Reichardt; Kirsten Sundby Hall; Jochen Schütte; Silke Cameron; Peter Hohenberger; Harri Sihto; Philipp J. Jost et al.
Source: check_circle
Crossref

Supplementary Figure S2 from <i>KIT</i> and <i>PDGFRA</i> Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial

2023-09-01 | Preprint
Contributors: Heikki Joensuu; Eva Wardelmann; Mikael Eriksson; Annette Reichardt; Kirsten Sundby Hall; Jochen Schütte; Silke Cameron; Peter Hohenberger; Harri Sihto; Philipp J. Jost et al.
Source: check_circle
Crossref

Supplementary Figure S3 from <i>KIT</i> and <i>PDGFRA</i> Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial

2023-09-01 | Preprint
Contributors: Heikki Joensuu; Eva Wardelmann; Mikael Eriksson; Annette Reichardt; Kirsten Sundby Hall; Jochen Schütte; Silke Cameron; Peter Hohenberger; Harri Sihto; Philipp J. Jost et al.
Source: check_circle
Crossref

Supplementary Figure S3 from <i>KIT</i> and <i>PDGFRA</i> Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial

2023-09-01 | Preprint
Contributors: Heikki Joensuu; Eva Wardelmann; Mikael Eriksson; Annette Reichardt; Kirsten Sundby Hall; Jochen Schütte; Silke Cameron; Peter Hohenberger; Harri Sihto; Philipp J. Jost et al.
Source: check_circle
Crossref

Supplementary Table S1 from <i>KIT</i> and <i>PDGFRA</i> Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial

2023-09-01 | Preprint
Contributors: Heikki Joensuu; Eva Wardelmann; Mikael Eriksson; Annette Reichardt; Kirsten Sundby Hall; Jochen Schütte; Silke Cameron; Peter Hohenberger; Harri Sihto; Philipp J. Jost et al.
Source: check_circle
Crossref

Supplementary Table S1 from <i>KIT</i> and <i>PDGFRA</i> Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial

2023-09-01 | Preprint
Contributors: Heikki Joensuu; Eva Wardelmann; Mikael Eriksson; Annette Reichardt; Kirsten Sundby Hall; Jochen Schütte; Silke Cameron; Peter Hohenberger; Harri Sihto; Philipp J. Jost et al.
Source: check_circle
Crossref

Data from Interdependence of SS18-SSX–driven YAP1 and β-Catenin Activation in Synovial Sarcoma

2023-06-01 | Preprint
Contributors: Ilka Isfort; Ruth Berthold; Lorena Heinst; Eva Wardelmann; Olle Larsson; Marcel Trautmann; Wolfgang Hartmann
Source: check_circle
Crossref

Figure S1 from Interdependence of SS18-SSX–driven YAP1 and β-Catenin Activation in Synovial Sarcoma

2023-06-01 | Preprint
Contributors: Ilka Isfort; Ruth Berthold; Lorena Heinst; Eva Wardelmann; Olle Larsson; Marcel Trautmann; Wolfgang Hartmann
Source: check_circle
Crossref

Figure S1 from Interdependence of SS18-SSX–driven YAP1 and β-Catenin Activation in Synovial Sarcoma

2023-06-01 | Preprint
Contributors: Ilka Isfort; Ruth Berthold; Lorena Heinst; Eva Wardelmann; Olle Larsson; Marcel Trautmann; Wolfgang Hartmann
Source: check_circle
Crossref

Figure S2 from Interdependence of SS18-SSX–driven YAP1 and β-Catenin Activation in Synovial Sarcoma

2023-06-01 | Preprint
Contributors: Ilka Isfort; Ruth Berthold; Lorena Heinst; Eva Wardelmann; Olle Larsson; Marcel Trautmann; Wolfgang Hartmann
Source: check_circle
Crossref

Figure S2 from Interdependence of SS18-SSX–driven YAP1 and β-Catenin Activation in Synovial Sarcoma

2023-06-01 | Preprint
Contributors: Ilka Isfort; Ruth Berthold; Lorena Heinst; Eva Wardelmann; Olle Larsson; Marcel Trautmann; Wolfgang Hartmann
Source: check_circle
Crossref

Figure S3 from Interdependence of SS18-SSX–driven YAP1 and β-Catenin Activation in Synovial Sarcoma

2023-06-01 | Preprint
Contributors: Ilka Isfort; Ruth Berthold; Lorena Heinst; Eva Wardelmann; Olle Larsson; Marcel Trautmann; Wolfgang Hartmann
Source: check_circle
Crossref

Figure S3 from Interdependence of SS18-SSX–driven YAP1 and β-Catenin Activation in Synovial Sarcoma

2023-06-01 | Preprint
Contributors: Ilka Isfort; Ruth Berthold; Lorena Heinst; Eva Wardelmann; Olle Larsson; Marcel Trautmann; Wolfgang Hartmann
Source: check_circle
Crossref

Figure S4 from Interdependence of SS18-SSX–driven YAP1 and β-Catenin Activation in Synovial Sarcoma

2023-06-01 | Preprint
Contributors: Ilka Isfort; Ruth Berthold; Lorena Heinst; Eva Wardelmann; Olle Larsson; Marcel Trautmann; Wolfgang Hartmann
Source: check_circle
Crossref

Figure S4 from Interdependence of SS18-SSX–driven YAP1 and β-Catenin Activation in Synovial Sarcoma

2023-06-01 | Preprint
Contributors: Ilka Isfort; Ruth Berthold; Lorena Heinst; Eva Wardelmann; Olle Larsson; Marcel Trautmann; Wolfgang Hartmann
Source: check_circle
Crossref

Figure S5 from Interdependence of SS18-SSX–driven YAP1 and β-Catenin Activation in Synovial Sarcoma

2023-06-01 | Preprint
Contributors: Ilka Isfort; Ruth Berthold; Lorena Heinst; Eva Wardelmann; Olle Larsson; Marcel Trautmann; Wolfgang Hartmann
Source: check_circle
Crossref
Items per page:
Page 1 of 2

Peer review (8 reviews for 6 publications/grants)

Review activity for Cancers. (1)
Review activity for Der Pathologe (1)
Review activity for Die Pathologie (2)
Review activity for European journal of surgical oncology. (1)
Review activity for Journal of cancer research and clinical oncology. (1)
Review activity for Virchows Archiv (2)